Sarecycline exhibits decreased activity Against Representative Bacterial and Fungal Microflora Commonly Present in the Human Gastrointestinal Tract. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 6, p. s83, 2021. DOI: 10.25251/skin.5.supp.83. Disponível em: https://skin.dermsquared.com/skin/article/view/1434. Acesso em: 18 apr. 2025.